Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:50 PM
Study NCT ID:
NCT07220551
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2025-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2025-10-22
First Submit QC Date:
None
Study First Post Date:
2025-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED